Activities per year
Activities
- 43 results
Search results
-
Searching for clinical biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Sabīne Grāvelsiņa (Speaker)
4 Feb 2022Activity: Talk or presentation types › Oral presentation
File -
What promotes development of fatigue in rheumatoid arthritis patients?
Anda Kadiša (Speaker), Zaiga Nora-Krūkle (Co-author), Lība Sokolovska (Co-author), Sabīne Grāvelsiņa (Co-author), Katrīne Vecvagare (Co-author), Šimons Svirskis (Co-author), Aivars Lejnieks (Co-author) & Modra Murovska (Co-author)
11 Jun 2022Activity: Talk or presentation types › Oral presentation
-
Post-COVID-19 consequences to public health
Diāna Arāja (Speaker), Uldis Berķis (Co-author) & Modra Murovska (Co-author)
20 Jun 2022Activity: Talk or presentation types › Oral presentation
File -
Involvement of viral infections in the development of non-communicable diseases
Modra Murovska (Speaker)
10 Jun 2022Activity: Talk or presentation types › Oral presentation
-
Involvement of persistent viral infections in the development of nervous system diseases (ME/CFS)
Modra Murovska (Speaker)
20 May 2022Activity: Talk or presentation types › Oral presentation
-
Involvement of persistent viral infections in the development of nervous system diseases
Modra Murovska (Speaker)
16 Mar 2021Activity: Talk or presentation types › Oral presentation
-
European network on myalgic encephalomyelitis/chronic fatigue syndrome – EUROMENE
Modra Murovska (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
-
European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Modra Murovska (Speaker)
16 Mar 2021Activity: Talk or presentation types › Oral presentation
-
Is there Clinically Significant Liver Injury in Acute COVID-19 and Post-COVID Period: Multimodal Imaging approach
Maija Radziņa (Speaker), Davis Simanis Putrins (Speaker), Ludmila Vīksna (Speaker), Ardis Platkājis (Speaker), Oksana Koļesova (Speaker) & Ieva Vanaga (Speaker)
28 Nov 2021 → 2 Dec 2021Activity: Talk or presentation types › Oral presentation
-
Whether parvoviruses are significant players in meningitis/meningoencephalitis?
Anda Vilmane (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
-
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Santa Rasa-Dzelzkalēja (Speaker)
30 Sep 2021Activity: Talk or presentation types › Oral presentation
-
Identification of bacterial lung infections and pre-existing persistent/chronic viral infections in COVID-19 patients
Anda Vilmane (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
-
Characterization Of Antibody Responses To SARS-CoV-2 Infection In COVID-19 Patients In Latvia
Samanta Strojeva (Speaker), Sabīne Grāvelsiņa (Co-author), Lība Sokolovska (Co-author), Zaiga Nora-Krūkle (Co-author), Maksims Čistjakovs (Co-author) & Modra Murovska (Co-author)
16 Jun 2021 → 18 Jun 2021Activity: Talk or presentation types › Oral presentation
-
Analysis of the chemokine receptor CCR1 mutations in patients with chronic lymphocytic leukemia
Laura Zvejniece (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
-
HHV-6 and thyroid autoimmunity: findings and questions
Lība Sokolovska (Speaker)
16 Mar 2021Activity: Talk or presentation types › Oral presentation
-
The use of the Luminex system in the context of autoimmunity research
Lība Sokolovska (Speaker)
28 Oct 2021Activity: Talk or presentation types › Oral presentation
-
SARS-CoV-2 un autoimunitāte: paradigma vai novitāte
Lība Sokolovska (Speaker)
7 Apr 2021Activity: Talk or presentation types › Oral presentation
-
The ever-present HHV-6 - a virus of autoimmunity
Lība Sokolovska (Speaker)
10 Nov 2021Activity: Talk or presentation types › Oral presentation
-
Fatigue and neurological impairment in long-haul COVID-19
Modra Murovska (Speaker)
27 Nov 2021 → 28 Nov 2021Activity: Talk or presentation types › Oral presentation
-
Inflammatory Chemokine Receptors in EBV Infection
Irina Holodņuka (Speaker)
16 Mar 2021Activity: Talk or presentation types › Oral presentation
-
Prevalence of KIR2DL2/DS2 and KIR2DL3 and presence of B19V in patients with thyroid disorders
Sabīne Grāvelsiņa (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
-
Potential Disruptive and Sustaining Innovations in Health Care
Diāna Arāja (Speaker)
14 May 2021Activity: Talk or presentation types › Oral presentation
-
Evaluation of possible SARS-CoV-2 fecal-oral transmission route in Latvian COVID-19 patients
Maksims Čistjakovs (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
-
Distribution of HLA class II allelic variants in patients with COVID-19 in Latvia
Laura Bajāre (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
-
Implications of RANTES in the development of autoimmune thyroiditis via chemokine production down-regulation by HHV-6
Lība Sokolovska (Speaker), Maksims Čistjakovs (Co-author), Alīna Sultanova (Co-author), Modra Murovska (Co-author) & Egils Cunskis (Co-author)
29 May 2021Activity: Talk or presentation types › Oral presentation
-
Machine learning: a brief description and application in infectious disease research
Šimons Svirskis (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
-
Detection Of SARS-CoV-2 In Various Clinical Specimens Of Hospitalized Latvian COVID-19 Patients
Lība Sokolovska (Speaker), Maksims Čistjakovs (Co-author), Sabīne Grāvelsiņa (Co-author), Zaiga Nora-Krūkle (Co-author) & Modra Murovska (Co-author)
17 Jun 2021Activity: Talk or presentation types › Oral presentation
-
Cytokine storm and COVID-19 severity
Zaiga Nora-Krūkle (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
-
Fatigue and neurological impairment in long-haul COVID-19
Modra Murovska (Speaker)
15 Sep 2021 → 17 Sep 2021Activity: Talk or presentation types › Oral presentation
-
Human Leucocyte Antigen class II risk and protective alleles in women with cervical intraepithelial neoplasia
Olga Plisko (Speaker), Jana Žodžika (Co-author), Dace Rezeberga (Co-author), Irina Jermakova (Co-author), Jeļena Eglīte (Co-author) & Diana Kasjko (Co-author)
8 May 2021Activity: Talk or presentation types › Oral presentation
-
Proportions of the Peripheral Blood Mononuclear Cells in Patients with Rheumatoid Arthritis
Irina Holodņuka (Speaker)
28 Oct 2021Activity: Talk or presentation types › Oral presentation
-
Clinical manifestation of HSV-1, HSV-2 or VHZ/HHV-3 in cervical cancer patients after treatment
Simona Doniņa (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
-
Inflammatory chemokine receptors in Epstein–Barr virus infection
Irina Holodņuka (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
-
Multiparametric Ultrasound Evaluation of Post-SARS-CoV-2 Liver Parenchymal Changes
Ludmila Vīksna (Speaker), Maija Radzina (Keynote speaker), Ardis Platkājis (Speaker), Arta Mičena (Speaker), Dāvis Sīmanis Putriņš (Speaker), Ieva Vanaga (Speaker) & Oksana Koļesova (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
-
Fibromyalgia - what we have done and what we plan to do
Zaiga Nora-Krūkle (Speaker)
16 Mar 2021Activity: Talk or presentation types › Oral presentation
-
Novel mechanism of HIV-1 driven carcinogenicity affecting epithelial cells
Maria Issagouliantis (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
-
Possible involvement of human herpesvirus-6 U12 and U51 gene coded proteins in the development of autoimmunity – an immunological investigation
Lība Sokolovska (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
-
COVID-19 and Obesity: Impact of Overweight on Disease Severity
Diāna Arāja (Speaker)
10 Dec 2020Activity: Talk or presentation types › Oral presentation
-
Pharmaceutical Enterprises' Market Entry Strategies
Diāna Arāja (Speaker)
2 Oct 2020Activity: Talk or presentation types › Oral presentation
-
Levels of expression of ORAI1 and STIM1 genes in blood with pulmonary tuberculosis and a control group.
Oksana Koļesova (Speaker)
28 Nov 2019Activity: Talk or presentation types › Oral presentation
-
Human Leucocyte Antigens Class II Alleles in Patients with Tuberculous Pneumonia in East Latvia.
Oksana Koļesova (Speaker)
28 Nov 2019Activity: Talk or presentation types › Oral presentation
-
Involvement of persistent viral infections in the development of nervous system diseases
Modra Murovska (Speaker)
25 Sep 2019Activity: Talk or presentation types › Oral presentation
-
Refractometric measuring system for determination of nanoparticle concentration
Vladimirs Kozlovs (Speaker)
12 Oct 2018Activity: Talk or presentation types › Oral presentation